The Beauty Health Company
SKIN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | 0.01 | -0.28 | -0.02 |
| FCF Yield | 4.74% | 2.12% | -9.23% | -1.78% |
| EV / EBITDA | 38.20 | -11.93 | 18.70 | -6.59 |
| Quality | ||||
| ROIC | -10.72% | -15.71% | -2.69% | -3.47% |
| Gross Margin | 54.53% | 38.97% | 68.00% | 68.65% |
| Cash Conversion Ratio | -0.55 | -0.22 | -2.40 | 0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.96% | 15.24% | 45.37% | 16.00% |
| Free Cash Flow Growth | 7.34% | 107.02% | -181.95% | -170.58% |
| Safety | ||||
| Net Debt / EBITDA | 19.16 | -4.28 | 2.25 | 0.44 |
| Interest Coverage | -6.51 | -9.59 | -1.93 | -3.39 |
| Efficiency | ||||
| Inventory Turnover | 2.20 | 2.66 | 1.07 | 2.31 |
| Cash Conversion Cycle | 144.35 | 120.43 | 330.66 | 99.97 |